首页> 美国卫生研究院文献>Open Heart >Protocol: Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS)
【2h】

Protocol: Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS)

机译:方案:先前进行非ST段抬高的急性冠脉综合征的冠状动脉搭桥手术患者的非侵入性与侵入性管理:飞行员随机对照试验和注册研究(CABG-ACS)的研究设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionThere is an evidence gap about how to best treat patients with prior coronary artery bypass grafts (CABGs) presenting with non-ST segment elevation acute coronary syndromes (NSTE-ACS) because historically, these patients were excluded from pivotal randomised trials. We aim to undertake a pilot trial of routine non-invasive management versus routine invasive management in patients with NSTE-ACS with prior CABG and optimal medical therapy during routine clinical care. Our trial is a proof-of-concept study for feasibility, safety, potential efficacy and health economic modelling. We hypothesise that a routine invasive approach in patients with NSTE-ACS with prior CABG is not superior to a non-invasive approach with optimal medical therapy.
机译:简介关于如何最好地治疗先前患有非ST段抬高的急性冠状动脉综合征(NSTE-ACS)的先前冠状动脉旁路移植术(CABG)的患者,尚存在证据空白,因为历史上,这些患者被排除在关键性随机试验之外。我们的目标是对先行CABG并在常规临床护理期间进行最佳药物治疗的NSTE-ACS患者进行常规无创治疗与常规有创治疗的试验性试验。我们的试验是关于可行性,安全性,潜在功效和健康经济模型的概念验证研究。我们假设在患有NSTE-ACS并伴有CABG的患者中,常规侵入性治疗方法并不优于采用最佳药物治疗的非侵入性治疗方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号